Cyclomics is a biotechnology company based in the Netherlands, focused on advancing cancer diagnostics through molecular biology, DNA sequencing, and AI. Our technologies, including CySeq® for consensus sequencing and liquid biopsy, and Epinn® for rapid tumor classification, help clinicians and researchers detect and monitor cancer and support more informed treatment decisions. We turn complex genomic data into actionable insights to help improve healthcare and life sciences worldwide.
| Website | http://www.cyclomics.com |
| Employees | 14 (7 on RocketReach) |
| Founded | 2018 |
| Address | Science Park 301, Amsterdam, North Holland 1098 XH, NL |
| Technologies |
JavaScript
,
HTML
,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology, Health Care |
| Keywords | Rna Sequencing, Bioinformatics Analysis, Genomic Research, Spatial Genomics, Genome Sequencing, Genomic Data Analysis, Next Generation Sequencing, Dna Sequencing, Ngs Data Analysis, Omics Data Analysis, High Throughput Sequencing, Transcriptomics, Molecular Biology, Epigenomics, Biotechnology, Life Sciences, Cancer Genomics, Drug Discovery, Precision Medicine |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, REVOLUTION Medicines, 10x Genomics, PacBio, Singular Genomics +40 more (view full list) |
Looking for a particular Cyclomics employee's phone or email?
Alessio Marcozzi is the Chief Scientific Officer of Cyclomics.
7 people are employed at Cyclomics.
Cyclomics is based in Amsterdam, North Holland.